Bronchogen (10 mg Vial) Dosage Protocol
Bronchogen is a synthetic tetrapeptide bioregulator (Ala-Glu-Asp-Pro) developed by Russian researchers, studied for bronchial epithelial regeneration and pulmonary support.
⚡ Quickstart Highlights
Dosing & Reconstitution Guide
Community-Reported Use Calculations (3 mL = 3.33 mg/mL)
| Research Period | Amount per Administration | U-100 Units (mL) |
|---|---|---|
| 10 days | 1 mg | 30 units (0.3 mL) |
| 20 days | 1 mg | 30 units (0.3 mL) |
| 10 days | 2 mg | 60 units (0.6 mL) |
| 20 days | 2 mg | 60 units (0.6 mL) |
Frequency: Once daily in the reviewed community descriptions. Each row is an independent calculation, not a titration schedule.
Research reference only: The 1 to 2 mg once-daily, 10 to 20 day patterns are nonclinical community descriptions. No academic Bronchogen study establishes these schedule numbers, a human route, or a validated recommendation.
Reconstitution Steps
- Clean the vial stopper and diluent stopper with alcohol; allow both to dry.
- Draw exactly 3.0 mL of bacteriostatic water with a new sterile syringe, then inject it slowly down the inside wall of the vial.
- Gently swirl or roll until dissolved. Do not shake.
- Label the vial with compound, concentration, and preparation date. Store it according to verified product-specific instructions.
This page is for research calculation and educational reference only. It is not medical advice or a direction for human use.
Supplies Needed
Calculated from the schedule above for a 10 mg vial reconstituted with 3 mL (one injection per day, two swabs per injection).
| Item | 10 days at 1 mg/day | 20 days at 1 mg/day | 10 days at 2 mg/day | 20 days at 2 mg/day |
|---|---|---|---|---|
| Peptide vials (10 mg each) | 1 vial (10 mg total) | 2 vials (20 mg total) | 2 vials (20 mg total) | 4 vials (40 mg total) |
| Insulin syringes (U-100) | 10 syringes | 20 syringes | 10 syringes | 20 syringes |
| Bacteriostatic water (10 mL bottles) | 3 mL → 1 × 10 mL bottle | 6 mL → 1 × 10 mL bottle | 6 mL → 1 × 10 mL bottle | 12 mL → 2 × 10 mL bottles |
| Alcohol swabs | 20 swabs → 1 × 100-count box | 40 swabs → 1 × 100-count box | 20 swabs → 1 × 100-count box | 40 swabs → 1 × 100-count box |
Protocol Overview
The hypothesized gene-expression mechanism produces effects that persist months after the cycle ends, supporting the cycled rather than continuous approach.
Storage Instructions
| State | Temperature | Duration |
|---|---|---|
| Lyophilized | −20°C (−4°F) | Up to 24 months, dry & dark |
| Reconstituted | 2–8°C (35–46°F) | Up to 30 days, protect from light |
Important Notes
How This Works
Bronchogen is one of the Khavinson tetrapeptide bioregulators — short peptides hypothesized to modulate gene expression in target tissues. Bronchogen targets bronchial epithelial cells, supporting tissue regeneration and reducing inflammation in chronic bronchitis models.
Potential Benefits & Side Effects
Potential Benefits
- Bronchial epithelial regeneration in animal models.
- Studied in chronic bronchitis and COPD support.
- Anti-inflammatory effects in airway tissue.
Side Effect Profile
- Generally well-tolerated.
- Mild injection-site reactions.
Lifestyle Factors
- Smoking cessation amplifies any pulmonary recovery.
- Adequate hydration supports mucociliary clearance.
Injection Technique
- Subcutaneous, rotate sites during cycle.